Consilium MedicumConsilium MedicumConsilium MedicumConsilium Medicum2075-17532542-2170Consilium Medicum9495210.26442/2075-1753_19.10.123-131ArticlesСтатьиReview ArticleProspects of bariatric interventions in patients with metabolic syndromeПерспективы бариатрических вмешательств у пациентов с метаболическим синдромомSalukhovV. VСалуховВладимир Владимирович

д-р мед. наук, нач. 1-й каф. (терапии усовершенствования врачей)

BlackM. SБлэкМарина Сергеевна

д-р мед. наук, ст. преподаватель 1-й каф. (терапии усовершенствования врачей)

BarsukovA. VБарсуковАнтон Владимирович

д-р мед. наук, проф., зам. нач. каф. госпитальной терапии

KharitonovM. AХаритоновМихаил Анатольевич

д-р мед. наук, проф., проф. 1-й каф. (терапии усовершенствования врачей)

SveklinaTS. SergeevnaСвеклинаТатьяна Сергеевна

канд. мед. наук, ассистент каф. пропедевтики внутренних болезней

VasilievE. VВасильевЕвгений Владимирович

врач-эндокринолог многопрофильного отд-ния

vlasaluk@yandex.ruS.M.Kirov Medical Military Academy of the Ministry of Defence of the Russian FederationФГБВОУ ВО «Военно-медицинская академия им. С.М.Кирова» Минобороны РоссииCity Hospital №40 of Kurortny districtСПб ГБУЗ «Городская больница №40 Курортного района»151020171910VOL 19, NO10 (2017)ТОМ 19, №10 (2017)12313128122021Copyright ©; 2017, Consilium MedicumCopyright ©; 2017, ООО "Консилиум Медикум"2017Consilium MedicumООО "Консилиум Медикум"https://creativecommons.org/licenses/by-nc-sa/4.0https://consilium.orscience.ru/2075-1753/article/view/94952

Metabolic syndrome (MS) rightly lies in the application of scientific and therapeutic and preventive efforts of modern medicine that unites the interests of specialists of various profiles due to its high prevalence, social weight and influence on the prognosis. The idea of appropriate metabolic, hormonal-regulatory, cardiovascular disorders, united within the MS, underscores the ambiguity of the pathogenesis of this condition, the difficulty of finding effective and safe methods of treatment in terms of comorbidity and prognostic significance. In the modern literature, the issue of prioritizing the use of bariatric interventions in obese individuals is being actively discussed. This review focuses on the possibilities of using metabolic surgery in a MS in the context of influencing other components included in this concept

Метаболический синдром (МС) по праву находится в плоскости применения научных и лечебно-профилактических усилий современной медицины, объединяющей интересы специалистов разного профиля в силу его высокой распространенности, социальной весомости и влияния на прогноз. Представление о соответствующих обменных, гормонально-регуляторных, кардиоваскулярных нарушениях, объединенных в рамках МС, подчеркивает неоднозначность патогенеза данного состояния, сложность поиска эффективных и безопасных с точки зрения коморбидности и прогностической значимости методов лечения. В современной литературе активно обсуждается вопрос приоритетности использования бариатрических вмешательств у лиц с ожирением. Настоящий обзор посвящен возможностям применения метаболической хирургии при МС в контексте влияния на другие компоненты, включаемые в это понятие

metabolic syndromeinsulin resistancebariatric surgeryметаболический синдроминсулинорезистентностьбариатрическая хирургияForouzanfar M.H,Alexander L, Anderson H.R et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 386: 2287-323.Kovesdy C.P, L Furth S, Zoccali C; World Kidney Day Steering Committee. Obesity and kidney disease: hidden consequences of the epidemic. Clin Kidney J 2017; 10 (1): 1-8. DOI: 10.1093/ckj/sfw139. PubMed PMID: 28638599. PubMed Central PMCID: PMC5469573.World Health Organization: Obesity and overweight fact sheet. http://www.who.int/mediacentre/factsheets/fs311/en/.Lane M, Zander-Fox D.L, Robker R.L, McPherson N.O. Peri-conception parental obesity, reproductive health, and transgenerational impacts. Trends Endocrinol Metab 2015; 26 (2): 84-90. DOI: 10.1016/j.tem.2014.11.005Ornellas F, Carapeto P.V, Mandarim-de-Lacerda C.A, Aguila M.B. Obese fathers lead to an altered metabolism and obesity in their children in adulthood: review of experimental and human studies. J Pediatr (Rio J) 2017. pii: S0021 -7557(16)30437-5. DOI: 10.1016/j.jped.2017.02.004. [Epub ahead of print] Review. PubMed PMID: 28822233.Ng M, Fleming T, Robinson M et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet Lond Engl 2014; 384 (9945): 766-81.Reaven G.M. Banting lecture - role of insulin resistance in human disease. Diabetes 1988; 13 (1): 1595-607.Alberti K.G, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006; 23: 469-80.Диагностика и лечение метаболического синдрома. Российские рекомендации, третий пересмотр. м., 2013.Симоненко В.Б., Горюцкий B.H., Дулин П.А. Роль инсулинорезистентности в патогенезе артериальной гипертонии. Клин. медицина. 2014; 9: 27-33./ Simonenko V.B., Goriutskii V.N., Dulin P.A. Rol' insulinorezistentnosti v patogeneze arterial'noi gipertonii. Klin. meditsina. 2014; 9: 27-33. [in Russian]Kotchen T.A. Obesity-related hypertension: epidemiology, pathophysiology, and clinical management. Am J Hypertens 2010; 23 (11): 1170-8. DOI: 10.1038/ajh.2010.172. PubMed PMID: 20706196.Han T.S, Lean M.E. A clinical perspective of obesity, metabolic syndrome and cardiovascular disease. JRSM Cardiovasc Dis 2016; 5: 2048004016633371. DOI: 10.1177/2048004016633371. eCollection 2016 Jan-Dec. Review. PubMed PMID: 26998259; PubMed Central PMCID: PMC4780070.Vaneckova I, Maletinska L, Behuliak M et al. Obesity-related hypertension: possible pathophysiological mechanisms. J Endocrinol 2014; 223 (3): R63-78. DOI: 10.1530/JOE-14- 0368. Review. PubMed PMID: 25385879.Nostedt J.J, Switzer N.J, Gill R.S. et al. The Effect of Bariatric Surgery on the Spectrum of Fatty Liver Disease. Can J Gastroenterol Hepatol 2016; 2016: 2059245. Published online 2016 Sep 29. DOI: 10.1155/2016/2059245 PMCID: PMC5061986.Quevedo M.D.P, Palermo M, Serra E, Ackermann M.A. Metabolic surgery: gastric bypass for the treatment of type 2 diabetes mellitus. Transl Gastroenterol Hepatol 2017; 2: 58. DOI: 10.21037/tgh.2017.05.10. eCollection 2017. Review. PubMed PMID: 28713862; PubMed Central PMCID: PMC5504088.Buchwald H, Varco R. Metabolic Surgery. New York: Grune & Stratton, 1978.Buchwald H, Avidor Y, Braunwald E et al. Bariatric surgery. A systematic review and metaanalysis. JAMA 2004; 292: 1724-37.Cefalu W.T, Bakris G, Blonde L et al. Standards of Medical Care in Diabetes 2017. Diabetes Care 2017; 40(Suppl. 1): S1-S2. DOI: 10.2337/dc17-S001Sjostrom L, Narbro K, Karason K et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357 (8): 741-52. DOI: 10.1056/NEJMoa066254Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И.Дедова, М.В.Шестаковой, А.Ю.Майорова. 8-й вып. м., 2017.Gletsu-Miller N, Wright B.N. Mineral malnutrition following bariatric surgery. Adv Nutr 2013; 4: 506-17. PMID: 24038242. DOI: 10.3945/an.113.004341Красильникова Е.И., Благосклонная Я.В., Быстрова А.А. и др. Адипозопатия - ключевое звено развития состояния инсулинорезистентности. Артериальная гипертензия. 2012; 18 (2): 164-76.Kelley D.E, Thaete F.L, Troost F. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol Endocrinol Metab 2000; 278: 941-8.Turkoglu C, Duman B.S, Gunay D et al. Effect of abdominal obesity on insulin resistance and the components of the metabolic syndrome: evidence supporting obesity as the central feature. Obes Surg 2003; 13 (5): 699-705.Gramann S, Wirsching J, Eichelmann F, Aleksandrova K. Association Between Peripheral Adipokines and Inflammation Markers: A Systematic Review and Meta-Analysis. Obesity (Silver Spring) 2017. DOI: 10.1002/oby.21945. [Epub ahead of print] PubMed PMID: 28834421.Свеклина T.C., Барсуков А.В., Таланцева М.С. Метаболический синдром и воспаление: актуальные вопросы патогенеза. Клин. лаб. диагностика. 2013; 3: 7-10. / Svek- lina T.S., Barsukov A.V., Talantseva M.S. Metabolicheskii sindrom i vospalenie: aktual'nye voprosy patogeneza. Klin. lab. diagnostika. 2013; 3: 7-10. [in Russian]Sjostrom L, Lindroos A, Peltonen M et al. Swedish Obese Subjects Study Scientific Group. Lifestyle, diabetes and cardiovascular risk factors 10 years after bariatric surger. N Eng J Med 2004;351:2683-93.IDF taskforce on the epidemiology and prevention, 2011.Heber D, Greenway F, Kaplan L et al. Endocrine and Nutritional Management of the PostBariatric Surgery Patient: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2010; 95 (11): 4823-43.Buchwald H, Estok R, Fahrbach K et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009; 122: 249-61.Rodieux F, Giusti V, Dalessio D et al. Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release. Obesity (Silver Spring) 2008; 16: 298-305.Svane M.S, Bojsen-M0ller K.N, Madsbad S. Medical therapy versus bariatric surgery of obese patients with Type 2 diabetes. Ugeskr Laeger 2016; 178 (44). pii: V06160418. Danish. PubMed PMID: 27808051.Raveendran A.V, Shiji P.V, Pappachan J.M. Role Of Bariatric Surgery In Type 2 Diabetes. BMH Med J 2017; 4 (1): 6-16.DiGiorgi M, Rosen D.J, Choi J.J et al. Re-emergence of diabetes after gastric bypass in patients with mid-to long-term follow-up. Surg Obes Rel Dis 2010; 6: 249-53.Ramos Y et al. Type 2 diabetes reemergence post-gastric bypass surgery, ENDO 2012: Abstract SAT-161.Dimitriadis G.K, Randeva M.S, Miras A.D. Potential Hormone Mechanisms of Bariatric Surgery. Curr Obes Rep 2017. DOI: 10.1007/s13679-017-0276-5. [Epub ahead of print] Review. PubMed PMID: 28780756.Evers S.S, Sandoval D.A, Seeley R.J. The physiology and molecular underpinnings of the effects of bariatric surgery on obesity and diabetes. Ann Rev Physiol 2017; 79: 313-34.Tsoli M, Chronaiou A, Kehagias I et al. Hormone changes and diabetes resolution after biliopancreatic diversion and laparoscopic sleeve gastrectomy: a comparative prospective study. Surg Obes Relat Dis 2013; 9: 667. DOI: 10.1016/j.soard.2012.12.006Lewis G.F, Carpentier A, Adeli K, Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 2002; 23: 201-29.Pories W, Dohm G. Full and Durable Remission of Type 2 Diabetes? Through Surgery? Surg Obes Relat Dis 2009; 5 (2): 285-8.Laferrere B, Heshka S, Wang K et al. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care 2007; 30: 1709-16.Буеверова Е.Л., Драпкина О.М., Ивашкин В.Т. Атерогенная дислипидемия и печень. Рос. мед. вести. 2008; 13 (1): 17-23. / Bueverova E.L., Drapkina O.M., Ivashkin V.T. Ate- rogennaia dislipidemiia i pechen'. Ros. med. vesti. 2008; 13 (1): 17-23. [in Russian]Ивашкин В.Т., Драпкина О.М., Корнеева О.Н. Клинические варианты метаболического синдрома. М.: Медицинское информационное агентство, 2012. / Ivashkin V.T., Drapkina O.M., Korneeva O.N. Klinicheskie varianty metabolicheskogo sindroma. M.: Meditsinskoe informatsionnoe agentstvo, 2012. [in Russian]Carswell K.A, Belgaumkar A.P, Amiel S.A, Patel A.G. A systematic review and meta-analysis of the effect of gastric bypass surgery on plasma lipid levels. Obes Surg 2016; 26 (4): 843-55.Savage D.B, Semple R.K. Recent insights into fatty liver, metabolic dyslipidaemia and their links to insulin resistance. Curr Opin Lipidol 2010; 21: 329-36.Bechmann L.P, Hannivoort R.A, Gerken G. et al. The interaction of hepatic lipid and glucose metabolism in liver diseases. J Hepatology 2012; 56 (4): 952-64.R6go A.D.S, Zulin A, Scolari S et al. Analysis of obese patients' medical conditions in the pre and postoperative periods of bariatric surgery. Rev Col Bras Cir 2017; 44 (2): 171-8. DOI: 10.1590/0100-69912017002011. English, Portuguese. PubMed PMID: 28658336.Jamal M, Wegner R, Heitshusen D et al. Resolution of hyperlipidemia follows surgical weight loss in patients undergoing Roux-en-Y gastric bypass surgery a 6-year analysis of data. Surg Obesity Related Dis 2011; 7 (4): 473-9.Silva C.F, Cohen L, Sarmento L.D et al. Effects of long-term Roux-En-Y gastric bypass on body weight and clinical metabolic comorbidities in bariatric surgery service of a university hospital. Arq Bras Cir Dig 2016; 29 (Suppl. 1): 20-3. DOI: 10.1590/0102- 6720201600S10006. English, Portuguese. PubMed PMID: 27683769; PubMed Central PMCID: PMC5064273.Ramos R.J, Mottin C.C, Alves L.B et al. Effects of size of intestinal diversions in obese patients with metabolic symdrome submitted to gastric bypass. Arq Bras Cir Dig 2016; 29 (Suppl. 1): 15-9. DOI: 10.1590/0102-720201600S10005. English, Portuguese. PubMed PMID: 27683768; PubMed Central PMCID: PMC5064282.Camastra S, Vitali A, Anselmino M et al. Muscle and adipose tissue morphology, insulin sensitivity and beta-cell function in diabetic and nondiabetic obese patients: effects of bariatric surgery. Sci Rep 2017; 7 (1): 9007. DOI: 10.1038/s41598-017-08444-6. PubMed PMID: 28827671; PubMed Central PMCID: PMC5566429.Anderwald C.H, Tura A, Promintzer-Schifferl M et al. Alterations in gastrointestinal, endocrine, and metabolic processes after bariatric Roux-en-Y gastric bypass surgery. Diabetes Care 2012; 35 (12): 2580-7. DOI: 10.2337/dc12-0197Rubino F, Nathan D.M, Eckel RHet al. Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: a Joint Statement by International Diabetes Organizations. Obes Surg 2017; 27: 2. DOI: 10.1007/s11695-016-2457-9Свеклина T.C. Комплексная клинико-анамнестическая, лабораторно-инструментальная и прогностическая оценка больных артериальной гипертензией в сочетании с сахарным диабетом 2 типа и фибрилляцией предсердий. Дис.. канд. мед. наук. СПб., 2011.Diez J. Altered regulation of the epithelial sodium channel in hypertension. From genes to therapeutics. J Hypertens 2011; 29 (2): 204-6.Корнеева O.H., Драпкина O.M. Патогенетические взаимосвязи артериальной гипертензии и инсулинорезистентности. Кардиология. 2006; 6: 61-4.Goossens G.H. The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulinresistance. Physiol Behav 2008; 94 (2): 206-18.Burns J, Ball S.G, Worthy G et al. Hypertensive left ventricular hypertrophy: a mechanistic approach to optimizing regression assessed by cardiovascular magnetic resonance. J Hypertens 2012; 30 (10): 2039-46.Govindarajan G. Obesity and hypertension: A clinical update. In: R.Ray, E.Schiffrin, J.R.Sowers, eds. Molecular mechanisms in hypertension. London: Taylor and Francis Pub, 2006; p. 397-406.Wang J, Wang H, Luo W et al. Leptin-induced endothelial dysfunction is mediated by sympathetic nervous system activity. J Am Heart Assoc 2013; 2 (5): e000299.Fernstrom J.D, Courcoulas A.P, Houck P.R, Fernstrom M.H. Long-term changes in blood pressure in extremely obese patients who have undergone bariatric surgery. Arch Surg 2006;141:276-83.Ahmed A.R, Rickards G, Coniglio D et al. Laparoscopic Roux-en-Y Gastric Bypass and Its Early Effect on Blood Pressure. Obes Surg 2008; 19 (7): 845-9.Dallal R.M, Hatalski A, Trang A, Chernoff A. Longitudinal analysis of cardiovascular parameters after gastric bypass surgery. Surg Obes Related Dis 2012; 8 (6): 703-9.Hinojosa M.W, Varela J.E, Smith B.R et al. Resolution of systemic hypertension after laparoscopic gastric bypass. J Gastrointest Surg 2009; 13 (4): 793-7.Inzucchi S.E. Diagnosis of Diabetes. N Engl J Med 2012; 367 (6): 542-50.Zafar M.I, Zheng J, Kong W et al. The Role of Vascular Endothelial Growth Factor-B in Metabolic Homeostasis: Current Evidence. Biosci Rep 2017. pii: BSR20171089. DOI: 10.1042/BSR20171089. [Epub ahead of print] PubMed PMID: 28798193.Салухов B.B., Васильев E.B., Слесарева Е.Г., Гладышев Д.В. Антропометрические показатели пациентов через 4-8 лет после бариатрических оперативных вмешательств. Мед. акад. журн. 2016; 16 (3): 29-31.Loomba R, Abraham M, Unalp A et al. Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis. Hepatology 2012; 56 (3): 943-51.Byrne C.D. Dorothy Hodgkin Lecture 2012 Non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management. Diabetic Medicine 2012; 29:1098-107.Doycheva I, Patel N, Peterson M, Loomba R. Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes. J Diabetes Complications 2013; 27 (3): 293-300.Chalasani N, Younossi Z, Lavine J.E. et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012; 55 (6): 2005-23.Pillaiand A.A, Rinella M.E. Nonalcoholic fatty liver disease: is bariatric surgery the answer? Clinics Liv Dis 2009; 13 (4): 689-710.Walenbergh S.M, Koek G, Bieqhs V, Shiri-Sverdlov R. Non-alcoholic steatohepatitis: the role of oxidized low-density lipoproteins. J Hepatology 2013; 58 (4): 801-10.Tilg H, Moschen A.R. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 2010; 52: 1836-46.Dongiovanni P, Valenti L, Rametta R. Genetic variants regulating insulin receptor signaling are associated with the severity of liver damage in patients with nonalcoholic fatty liver disease. Gut 2010; 59: 267-73.Bower G, Toma T, Harling L et al. Bariatric surgery and non-alcoholic fatty liver disease: a systematic review of liver biochemistry and histology. Obes Surg 2015; 25 (12): 2280-9.Alizai P.H, Wendl J, Roeth A.A et al. Functional liver recovery after bariatric surgery - a Prospective Cohort Study with the LiMAx Test. Obes Surg 2015; 25 (11): 2047-53.Taitano A.A, Markow M, Finan J.E. et al. Bariatric surgery improves histological features of nonalcoholic fatty liver disease and liver fibrosis. J Gastrointestinal Surgery 2015; 19 (3): 429-37.Lassailly G, Caiazzo R, Buob D et al. Bariatric surgery reduces features of non-alcoholic steatohepatitis in morbidly obese patients. Gastroenterology 2015; 149: 377-88.EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatology 2016; 64:1388-402. [in Russian]Ghiassi S, Morton J, Bellatorre N, Eisenberg D. Short-term medication cost savings for treating hypertension and diabetes after gastric bypass. Surg Obes Relat Dis 2012; 8 (3): 269-74.